SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001062993-20-004064
Filing Date
2020-08-18
Accepted
2020-08-18 15:37:21
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 16962
2 FORM 1A/A form1aa4.htm PART II AND III 878013
3 EXHIBIT 1A14.1 exhibit1a-141.htm EX1A-14 CNSNT SV 9748
4 tmpx001.jpg GRAPHIC 5917
5 tmpx002.jpg GRAPHIC 4443
  Complete submission text file 0001062993-20-004064.txt   920303
Mailing Address 1177 WEST HASTINGS STREET, SUITE 2300 VANCOUVER A1 V6E 2K3
Business Address 1177 WEST HASTINGS STREET, SUITE 2300 VANCOUVER A1 V6E 2K3 604-679-2776
Shackelford Pharma Inc. (Filer) CIK: 0001811112 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 1-A/A | Act: 33 | File No.: 024-11206 | Film No.: 201113388
SIC: 2834 Pharmaceutical Preparations